Ardena appoints new Chief Quality Officer and Chief Information Officer
Charlie Blackie-Kelly | November 6, 2025 | Appointment | | Ardena, CDMO, CRO, Chief Information Officer, chief quality officer
Ardena, a specialist pharmaceutical contract development and manufacturing organisation (CDMO) and bioanalytical contract research organisation (CRO) focusing on precision medicines, has appointed Dipesh Patel as Chief Quality Officer (CQO) and Peter Rose as Chief Information Officer (CIO).
Patel joins Ardena from Accord Healthcare, where he served as Senior Vice President of Quality. He previously held leadership roles at Catalent, including Vice President of Quality and Site General Manager. With extensive experience overseeing a wide range of dosage forms and navigating diverse regulatory frameworks, Patel will lead Ardena’s quality and regulatory division. In his new role, he will be responsible for ensuring continued compliance, strengthening global processes and advancing operational excellence.
Rose most recently served as Global Head of IT Infrastructure and Security at Diversey, a global chemical manufacturer, where he led the company’s IT migration into the Solenis Group and drove technology-enabled transformations across operations. Prior to that, he spent a decade at Catalent, overseeing global IT systems, following earlier service in the Royal Air Force as an aircraft engineer. As CIO, Rose will focus on enhancing Ardena’s digital infrastructure through increased integration of automation, AI and cybersecurity technologies.
“These appointments mark an important step in strengthening Ardena’s foundation as we accelerate our global growth journey and expand the capabilities that enable next-generation precision medicines.” said Jeremie Trochu, Ardena’s Chief Executive Officer.
“Our continued investment in IT integration and digital infrastructure is transforming how we operate – advancing productivity, automation, and AI to support sustainable growth. At the same time, our strong regulatory track record and deep commitment to quality remain the backbone of our operations. With Dipesh and Peter joining our leadership team, we continue to build on our culture of operational excellence and integrated solutions for our customers, aligned with our mission to enable the development of next generation treatments get into the clinic and to patients faster.”
Related Content
Recipharm designates Germany site as Centre of Excellence
The multi-product facility recently underwent significant renovations
Crown Bioscience opens new US model development centre
Crown Bioscience, a US global contract research organisation (CRO) that is part of JSR Life …
Bend Bioscience adds commercial spray drying facility to Georgia site
Bend Bioscience has announced the addition of a commercial-scale spray dryer and a Gerteis dry …
